Korean J Fam Med.  2025 May;46(3):204-209. 10.4082/kjfm.24.0210.

Fasting is not always good: perioperative fasting leads to pronounced ketone body production in patients treated with SGLT2 inhibitors: a case report

• Choi JC
• Jang YN
• Lee JH
• Park SW
• Park JA
• Kim HS
• Choi JW
• Lee JH
• Lee YJ

• KMID: 2568009
• DOI: http://doi.org/10.4082/kjfm.24.0210

Abstract

Ketone bodies produced by sodium-glucose cotransporter 2 (SGLT2) inhibitors can be advantageous, providing an efficient and stable energy source for the brain and muscles. However, in patients with diabetes, ketogenesis induced by SGLT2 inhibitors may be harmful, potentially resulting in severe diabetic ketoacidosis (DKA). During fasting, ketone body production serves as an alternative and efficient energy source for the brain by utilizing stored fat, promoting mental clarity, and reducing dependence on glucose. The concurrent use of SGLT2 inhibitors during perioperative fasting may further elevate the risk of euglycemic DKA. We describe a case of DKA that occurred during perioperative fasting in a patient receiving empagliflozin, an SGLT2 inhibitor. This case underscores the importance of recognizing the potential risk of DKA in patients with diabetes using SGLT2 inhibitors during perioperative fasting.

Keyword

Sodium-Glucose Transporter 2 Inhibitors; Diabetic Ketoacidosis; Fasting; Preoperative Care; Case Reports